These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34067578)

  • 1. Urine and Serum Electrolytes and Biochemical Values Associated with Osteoporosis in Premenopausal and Postmenopausal Women: A Longitudinal and Cross-Sectional Study Using Korean Genome and Epidemiology Study (KoGES) Cohort.
    Park HS; Kim GY; Lo JA; Kim JS; Ahn SY; Ko GJ; Kwon YJ; Kim JE
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34067578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
    Han W; Bai X; Wang N; Han L; Sun X; Chen X
    Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Iki M; Morita A; Ikeda Y; Sato Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2006; 17(7):1086-95. PubMed ID: 16758145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
    Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
    Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone density change and biochemical indices of skeletal turnover.
    Cosman F; Nieves J; Wilkinson C; Schnering D; Shen V; Lindsay R
    Calcif Tissue Int; 1996 Apr; 58(4):236-43. PubMed ID: 8661954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between platelet count and bone mineral density: results from two independent population-based studies.
    Kim J; Kim HS; Lee HS; Kwon YJ
    Arch Osteoporos; 2020 Mar; 15(1):43. PubMed ID: 32166543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Alkaline Phosphatase and Urine Hydroxyproline Assay in Pre and Postmenopausal Women in the State of Sikkim and its Correlation with Bone Mineral Density.
    Rai AD; Sherpa ML; Singh A; Thejaswi SG; Bhutia RD
    J Midlife Health; 2021; 12(4):304-309. PubMed ID: 35264838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
    Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of osteoporosis among North Korean women refugees living in South Korea: a comparative cross-sectional study.
    Kim KJ; An JH; Kim KJ; Yu JH; Kim NH; Yoo HJ; Kim HY; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG
    BMJ Open; 2020 Jun; 10(6):e036230. PubMed ID: 32532773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Associations between Bone Mineral Density and Oxidative Stress Biomarkers in Postmenopausal Women.
    Malekian S; Mirghafourvand M; Najafipour F; Ostadrahimi A; Ghassab-Abdollahi N; Farshbaf-Khalili A
    Korean J Fam Med; 2023 Mar; 44(2):95-101. PubMed ID: 36966739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in relation to medical and lifestyle risk factors for osteoporosis in premenopausal, menopausal and postmenopausal women in general practice.
    McKnight A; Steele K; Mills K; Gilchrist C; Taggart H
    Br J Gen Pract; 1995 Jun; 45(395):317-20. PubMed ID: 7619589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis.
    Koh JM; Khang YH; Jung CH; Bae S; Kim DJ; Chung YE; Kim GS
    Osteoporos Int; 2005 Oct; 16(10):1263-71. PubMed ID: 15702263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008-2010.
    Chon SJ; Choi YR; Roh YH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
    PLoS One; 2014; 9(12):e114972. PubMed ID: 25522357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis.
    Garnero P; Borel O; Delmas PD
    Clin Chem; 2001 Apr; 47(4):694-702. PubMed ID: 11274020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the risk factors for osteoporosis among postmenopausal women.
    Demir B; Haberal A; Geyik P; Baskan B; Ozturkoglu E; Karacay O; Deveci S
    Maturitas; 2008; 60(3-4):253-6. PubMed ID: 18778903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women.
    Adolf D; Wex T; Jahn O; Riebau C; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S; Piatek S
    Maturitas; 2012 Feb; 71(2):169-72. PubMed ID: 22197348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.